Medical Xpress November 29, 2024
Until recently, human vaccine development has typically taken 10 to 15 years.
But during the COVID-19 pandemic, vaccines like the Vaxzevria vaccine produced by the University of Oxford and AstraZeneca were developed and licensed within a single year.
This remarkable achievement was made possible through:
- the sharing of pre-existing knowledge
- platform delivery technologies
- active, positive collaboration between researchers and regulators
Rapid human vaccine development map
A newly developed process map includes a rapid human vaccine development (RHVD) case study created using the COVID-19 vaccine as an exemplar.
It will build on this experience and use the lessons learned to:
- help researchers boost capacity
- avoid setbacks
- respond rapidly to future health challenges and pandemics
The process map...